CN103933336A - Traditional Chinese medicine combination for treating leucoderma - Google Patents

Traditional Chinese medicine combination for treating leucoderma Download PDF

Info

Publication number
CN103933336A
CN103933336A CN201410150690.9A CN201410150690A CN103933336A CN 103933336 A CN103933336 A CN 103933336A CN 201410150690 A CN201410150690 A CN 201410150690A CN 103933336 A CN103933336 A CN 103933336A
Authority
CN
China
Prior art keywords
chinese medicine
vitiligo
radix
leucoderma
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410150690.9A
Other languages
Chinese (zh)
Inventor
孙中
舒双平
孙大荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANGXI COUNTY ZHIRUI ENTERPRISE INFORMATION SERVICE Co Ltd
Original Assignee
LANGXI COUNTY ZHIRUI ENTERPRISE INFORMATION SERVICE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANGXI COUNTY ZHIRUI ENTERPRISE INFORMATION SERVICE Co Ltd filed Critical LANGXI COUNTY ZHIRUI ENTERPRISE INFORMATION SERVICE Co Ltd
Priority to CN201410150690.9A priority Critical patent/CN103933336A/en
Publication of CN103933336A publication Critical patent/CN103933336A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a traditional Chinese medicine combination for treating leucoderma, which relates to the technical field of medicine. The traditional Chinese medicine combination for treating leucoderma is composed of 4-6g of pillis ophidiae, 4-6g of mint, 5-7g of monkshood, 5-7g of radix ophiopogonis, 5-7g of clove, 4-6g of radix angelicae, 9-11g of platycodon grandiflorum, 9-11g of potassium nitrate, 45-55g of vernonia anthelmintica and 9-11g of flowers carthami, wherein all the raw material medicines are soaked for one month with 200ml of alcohol, and filtered to prepare the medicine solution for an externally applied liniment for leucoderma. The traditional Chinese medicine combination for treating leucoderma disclosed by the invention is reasonable in compatibility, good in treatment effect on leucoderma, capable of dispelling wind, detoxifying, promoting blood circulation to remove meridian, diverging hair and apertures, improving the qi-blood circulation of the skin and diffusing wind heat and capable of stimulating the generation of melanocytes and the secretion of melanin after being applied externally.

Description

One is used for the treatment of vitiligo Chinese medicine composition
Technical field
The present invention relates to medical technical field, be specifically related to one and be used for the treatment of vitiligo Chinese medicine composition.
Background technology
Vitiligo is a kind of common skin diseases, and this disease is that the de-mistake formation of skin pigment day after tomorrow white macula is feature, and etiology and pathogenesis is more complicated, is the result of many factors comprehensive function.In recent years, most scholars think that vitiligo is a kind of autoimmune disease of polygenic inheritance, and humoral immunization and cellular immunization play an important role in vitiligo forms to melanocytic destruction.Impact beauty treatment, easily diagnoses refractory to treat.This disease all has generation all over the world, and Africa and India's sickness rate are higher, China's sickness rate approximately 2%, and southern and northern sickness rate and men and women's sickness rate are without significant difference.
Chinese medicine thinks, leukodermic Etiological pathogenesis is stagnation of QI due to depression of the liver, deficiency of the liver and kindey, stagnation of QI-blood.Exopathogen is taken advantage of a weak point in opponent's defence and is attacked, and visitor enters flesh table, and meridians are obstructed, coagulation of QI-blood, and fur space between skin and muscles loses supports and the speckle that turns white.12 meridians, eight extra-channel are invaded by pathogenic factor all can, and all can fall ill in any position of body surface, have bilateral symmetric property characteristics of incidence, the how double congestion of course of disease elder.Lung governing qi, at body and skin, its Hua Mao.Have Xuan Fawei gas, semen deposition is in physiological functions such as furs.Treat more difficultly, be a difficult problem medically always.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of component simple, and eutherapeutic one is used for the treatment of vitiligo Chinese medicine composition.
Technical problem to be solved by this invention realizes by the following technical solutions:
One is used for the treatment of vitiligo Chinese medicine composition, by Rhizoma aspidistrae luridae 4-6g, Herba Menthae 4-6g, Radix Aconiti 5-7g, Radix Ophiopogonis, 5-7g, Flos Caryophylli 5-7g, Radix Angelicae Dahuricae 4-6g, Radix Platycodonis 9-11g, potassium nitrate 9-11g, Caulis Vernoniae andersonii 45-55g, Flos Carthami 9-11g form, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
The optimum weight proportioning of each component is: Rhizoma aspidistrae luridae 5g, Herba Menthae 5g, Radix Aconiti 6g, Radix Ophiopogonis 6g, Flos Caryophylli 6g, Radix Angelicae Dahuricae 5g, Radix Platycodonis 10g, potassium nitrate 10g, Caulis Vernoniae andersonii 50g, Flos Carthami 10g, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
Using method: twice, morning and evening every day each wiping white macula position.
Clinical observation: normally use 3-7 days white maculas to redden, white macula edge forms in white and black border; Use 30-40 days, white macula position has melanin all to produce.The white macula of general coin-size can rehabilitation about 4 months, and egg size white macula 6 months can rehabilitation.
The present invention, by Caulis Vernoniae andersonii and Flos Carthami and the same use of potassium nitrate, has changed the mode of tradition as oral medicine, is prepared into liniment, has improved drug effect, and liniment is easy to preserve, and it is also convenient to use.
Clinical experiment
1, case source
Choose 550 routine patients with vitiligo at the each large Dermatology of this city, topical type in patient, distribute type, acra type, all have without general hair style.Wherein male's 240 examples, women's 310 examples, the course of disease is between half a year to 8 year, and average course of disease is 3.23, and patient age is between 18-50 year.
2, test method
Patient uses medicine wiping affected part of the present invention, and every day 4 times, each 2 times sooner or later, every minor tick 30 minutes, uses 3 months continuously.
3, criterion of therapeutical effect
Effective: white macula disappears completely or white macula area reducing is greater than 70%;
Effective: white macula area reducing, white macula area reducing is greater than 50%;
Invalid: the unchanged or white macula area reducing of white macula is less than 10%.
4, therapeutic outcome
Number of cases Effective Effectively Invalid Effective percentage (%)
550 247 295 8 98
The invention has the beneficial effects as follows: medicine compatibility of the present invention is reasonable, good to vitiligo therapeutic effect, the external removing toxic substances of can dispeling the wind, promoting blood circulation to remove obstruction in the collateral, disperses a mao key, and the QI-blood circulation and a surname that increase skin issue loose effect, stimulate melanocyte to generate and melanic secretion.
Detailed description of the invention
For technological means, creation characteristic that the present invention is realized, reach object and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
One is used for the treatment of vitiligo Chinese medicine composition, by Rhizoma aspidistrae luridae 6g, Herba Menthae 6g, Radix Aconiti 7g, Radix Ophiopogonis, 7g, Flos Caryophylli 7g, Radix Angelicae Dahuricae 6g, Radix Platycodonis 11g, potassium nitrate 11g, Caulis Vernoniae andersonii 55g, Flos Carthami 11g form, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
Embodiment 2
One is used for the treatment of vitiligo Chinese medicine composition, by Rhizoma aspidistrae luridae 5g, Herba Menthae 5g, Radix Aconiti 6g, Radix Ophiopogonis, 6g, Flos Caryophylli 6g, Radix Angelicae Dahuricae 5g, Radix Platycodonis 10g, potassium nitrate 10g, Caulis Vernoniae andersonii 50g, Flos Carthami 10g form, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
Embodiment 3
One is used for the treatment of vitiligo Chinese medicine composition, by Rhizoma aspidistrae luridae 4g, Herba Menthae 4g, Radix Aconiti 5g, Radix Ophiopogonis, 5g, Flos Caryophylli 5g, Radix Angelicae Dahuricae 4g, Radix Platycodonis 9g, potassium nitrate 9g, Caulis Vernoniae andersonii 45g, Flos Carthami 9g form, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
Model case
Case 1
Case 1
Just certain, female, 6 years old, Dangshan County Huang Tun people from village.Patient's right frontal eminence of being born has the melanotic nevus that sesame seed is large, and during by four years old, melanotic nevus has beans large, and long around have a vitiligo, with medicine wiping of the present invention after two months, vitiligo is cured, melanotic nevus also disappears thereupon, skin color is normal.
Case 2
Lee so-and-so, female, 26 years old, Dangshan County Zhu Zhuan people from village.Auris dextra future trouble vitiligo is as large in monobasic coin, and with medicine wiping of the present invention, after one month, it is normal that skin color recovers.
Case 3
Zhu, female, 17 years old, Dangshan County Zhu Zhuan people.Right lower limb has Liang Chu, right volume to have a place to suffer from vitiligo, has thumbnail, after medicine wiping of the present invention is after three months, is cured, and skin color is normal.
Case 4
Rely so-and-so, man, 32 years old, Dangshan County great Zhai people from village.Before and after left ear, before right arm, in hair, right front and waist many places suffer from vitiligo, the about 4-5 centimetre of bulk is wide, differs in size.After one month, cure with medicine wiping of the present invention.
More than show and described ultimate principle of the present invention and principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; that in above-described embodiment and description, describes just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.

Claims (2)

1. one kind is used for the treatment of vitiligo Chinese medicine composition, it is characterized in that: by Rhizoma aspidistrae luridae 4-6g, Herba Menthae 4-6g, Radix Aconiti 5-7g, Radix Ophiopogonis, 5-7g, Flos Caryophylli 5-7g, Radix Angelicae Dahuricae 4-6g, Radix Platycodonis 9-11g, potassium nitrate 9-11g, Caulis Vernoniae andersonii 45-55g, Flos Carthami 9-11g form, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
2. one according to claim 1 is used for the treatment of vitiligo Chinese medicine composition, it is characterized in that: by Rhizoma aspidistrae luridae 5g, Herba Menthae 5g, Radix Aconiti 6g, Radix Ophiopogonis, 6g, Flos Caryophylli 6g, Radix Angelicae Dahuricae 5g, Radix Platycodonis 10g, potassium nitrate 10g, Caulis Vernoniae andersonii 50g, Flos Carthami 10g form, use 200ml after alcohol-pickled one month each taste crude drug, filter, make medicinal liquid, for the outer liniment of vitiligo.
CN201410150690.9A 2014-04-15 2014-04-15 Traditional Chinese medicine combination for treating leucoderma Pending CN103933336A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410150690.9A CN103933336A (en) 2014-04-15 2014-04-15 Traditional Chinese medicine combination for treating leucoderma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410150690.9A CN103933336A (en) 2014-04-15 2014-04-15 Traditional Chinese medicine combination for treating leucoderma

Publications (1)

Publication Number Publication Date
CN103933336A true CN103933336A (en) 2014-07-23

Family

ID=51181392

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410150690.9A Pending CN103933336A (en) 2014-04-15 2014-04-15 Traditional Chinese medicine combination for treating leucoderma

Country Status (1)

Country Link
CN (1) CN103933336A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079041A (en) * 2018-01-12 2018-05-29 黄发 A kind of external medicinal liquid for treating vitiligo and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101049340A (en) * 2006-04-05 2007-10-10 李秋科 Composition of medication for treating leucoderma, and preparation method
CN101711804A (en) * 2009-12-01 2010-05-26 何江思 Traditional Chinese medicine paste for treating leukoderma diseases
CN102335312A (en) * 2011-10-25 2012-02-01 张志常 Chinese medicine for treating vitiligo
CN102335322A (en) * 2011-09-26 2012-02-01 张树臣 Medicine formula for treating leucoderma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101049340A (en) * 2006-04-05 2007-10-10 李秋科 Composition of medication for treating leucoderma, and preparation method
CN101711804A (en) * 2009-12-01 2010-05-26 何江思 Traditional Chinese medicine paste for treating leukoderma diseases
CN102335322A (en) * 2011-09-26 2012-02-01 张树臣 Medicine formula for treating leucoderma
CN102335312A (en) * 2011-10-25 2012-02-01 张志常 Chinese medicine for treating vitiligo

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079041A (en) * 2018-01-12 2018-05-29 黄发 A kind of external medicinal liquid for treating vitiligo and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103751633B (en) A kind of Chinese medicine composition and its preparation method treating Varicose veins of lower extremity
CN102114217B (en) Traditional Chinese medicine fumigant for treating tinea capitis
CN101637512A (en) Traditional Chinese medicine preparation for treating vitiligo
CN103656244B (en) The Local Nursing Care thing that a kind of improvement is uncomfortable after lancinating and hindering wound healing
CN106308277A (en) Medicinal pillow having efficacies for cervical spondylosis and preparation method of medicinal pillow
CN103948684B (en) A kind of outer liniment being used for the treatment of vitiligo
CN103933336A (en) Traditional Chinese medicine combination for treating leucoderma
CN104189306A (en) Medicine used for treating peripheral facial neuritis
CN107714798A (en) A Chinese medicinal composition for treating chloasma, and its preparation method
CN102861303B (en) External plaster for treating cough, asthma and gynecologic inflammation
CN103816233A (en) Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo
CN105796714A (en) Traditional Chinese medicine acupoint plaster
CN105194227A (en) Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills
CN103735874B (en) A kind of nursing powder for wound after wound healing and preparation method thereof
CN105853833A (en) Traditional Chinese medicine wine for treating tinnitus and preparation method thereof
CN105521391A (en) Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine
CN104306950B (en) It is a kind of to treat External-applicationtraditional traditional Chinese medicinal of rhinitis and its production and use
CN104983882A (en) Traditional Chinese medicine composition for treating obstructive sleep apnea and hypoventilation syndrome
CN103948804B (en) A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale
CN105796972A (en) Chinese medicinal formula for traditional Chinese medicine acupuncture and moxibustion and preparation method
CN104840784A (en) Vitiligo eliminating ointment
CN107693740A (en) A kind of yin-nourishing heat-clearing sachet and preparation method thereof
CN107638543A (en) Treatment by Chinese herbs leucoderma and preparation technology
CN107789488A (en) A kind of traditional Chinese herbal decoction for being used to treat encephalic fungal granuloma
CN108186829A (en) A kind of herbal composite for treating rhinitis chronic and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140723